Co-administration of treatment for rifampicin-resistant tuberculosis and chronic hepatitis C virus infection: a TBnet and ESGMYC study

Authors :: Lorenzo Guglielmetti
Christophe Rioux
Christoph Lange
Simone Tunesi
Esgmyc
Valérie Pourcher
Maria Musso
Mathilde Jachym-Frechet
Joan-Pau Millet
Fabrizio Palmieri
Gina Gualano
Aliaksandr Skrahin
Tbnet
Alena Skrahina
Dzmitry Viatushka
Damien Le Dû
Nicolas Veziris
Xavier Casas
Graham H. Bothamley
Delia Goletti
Publication Year :: 2021
Publisher :: Cold Spring Harbor Laboratory, 2021.
Abstract: Concomitant treatment for chronic hepatitis C virus infection and multidrug-resistant tuberculosis is safe and effective.

Subjects :: Tuberculosis
Chronic hepatitis
Rifampicin resistant tuberculosis
business.industry
Concomitant
medicine
medicine.disease
business
Virology
Virus
Co administration

Tools